8[2]Lanza G, Gafa R, Santini A, et al. Prognostic significance of DNA ploidy in patients with stage Ⅱ and stage Ⅲcolon carcinoma[J ]. Cancer, 1998,82(1) :49.
9[3]Lucha PA, Rosen L, Olenwine JA, et al. Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma [J ]. Dis Colon Rectum,1997,40(2) : 145.
10[4]Nilsson D,Johansson C,Glimelins B,et al. Sensitivity and specitivity of CA242 in gastrointestinal cancer. A comparison with CEA. CA50 and CA19-9[J]. Br J Cancer, 1992,65(2) :215.
3Espey D,Palsano R,Cobb N.Regional patients and trends in cancer mortality among American Indians and Alaska Natives,1990-2001[J].Cancer,2005,103(5):1 045-1 053.
4Mitry E,Benhamiche AM,Jouve JL,et al.Colorectal adenocar-cinoma patients under 45 years of age:comparison with older patients in a well-defined French population[M].Dis Colon Rectum,2001,3(44):380-387.
5Okuno MD.Colorectal carcinoma in patients younger than 40 of age:Montpezlier cancer institute experience with 78 patients[J].Caner,1988,61(4):8 264-8 268.
6Yeu-Tsu M.Lee,Carcinoma of colon and rectum:distribution of metastatic sites,risk factors and autopsy studies[J].Glcaner,1998,2(14):255-266.
7Keswani SG,Boyle MJ,Maxwel JP,et al.Colorectal caner in patients Younger than 40 year s of age[J].Am Surg,2002,68(10):871-876.
8Avital S,Kashtan H,Hadad R,et al.Survival of colorectal carcinoma in the elderly.A prospective study of colorectal carcinoma and Sfive-year follow-up[J].Dis Colon Rectum,1997,40(5)1523-529.
9Spitzer WO,Dobson AJ,Hall J,et al.Measuring the quality of life of cancer patie -nts:a concise QL-index for use by physicians[J].J Chronic Dis,2008,34(12): 585-597.
10Yeu-T su M.Carcinom a of colon and rectum: distribution of metastatic sites,risk factors and autopsy studies[J].G lcaner,2008, 2(14):255- 266.
